Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Stress Disorders, Post-Traumatic 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Depression 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Etoposide 20Cisplatin 20Carboplatin 19Topotecan 13pembrolizumab 11durvalumab 11Paclitaxel 10Irinotecan 9Nivolumab 7Gemcitabine 7tremelimumab 6atezolizumab 6Radiotherapy 6Docetaxel 6Pemetrexed 5Ipilimumab 5Cyclophosphamide 5rovalpituzumab tesirine 4budigalimab 4Specimen Handling 4Injections 4Doxorubicin 4Bortezomib 4130-nm albumin-bound paclitaxel 4venetoclax 3talazoparib 3olaparib 3fludarabine 3etoposide phosphate 3Platinum 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Small Cell Lung Carcinoma × Methods × Clear all
NCT01457469 2018-08-01

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer

Wake Forest University Health Sciences

Phase 1 Completed
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Tobacco Use Disorder, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡